top of page

Partner specialised in

  •  Lab-on-a-foil components 

  • Manufacturing processes for IVD consumables

  • Electrochemical sensors

  • Inline monitoring systems

#MIHfamily member
JOANNEUM RESEARCH Forschungsgesellschaft mbH (JR)

Pioneering Next-Generation Microfluidics

As a nationally and internationally active research institution, JR innovates in fields like Information and Production Technologies, Human Technologies and Medicine, and Society and Sustainability. Their MATERIALS Institute is focused on the manufacturing value chain for lab-on-a-foil components, developing a range of technologies including roll-to-roll UV-NIL patterning, microarray spotting, bio-reagent dispensing, and UV-based lamination. They are also involved in manufacturing processes for an IVD consumable for COVID-19 antibody detection. The HEALTH Institute contributes to the design and development of electrochemical sensors for medical applications, including a system for smartphone-based blood potassium quantification. The DIGITAL Institute brings expertise in image acquisition and analysis, contributing an inline monitoring system to the manufacturing line to ensure high quality of imprinted structures​.

Projects involved in

Image of Accunea's Kidney Transplants Innovation - microfluidic detection.

Accunea's Kidney Viability Monitoring Device

In a significant advancement for the field of organ transplantation, the Microfluidics Innovation Hub (MIH) is proud to announce a pioneering collaboration with Accunea. This initiative marks a pivotal moment in our endeavor to push the boundaries of healthcare through the integration of innovative microfluidics technology.

Lab-on-a-cartridge system showcasing its modular components, sensor region, and various detection capabilities.

Biosensors for Food Safety & Public Health Monitoring

Development of a versatile lab-on-a-cartridge platform for rapid, multiplexed detection of pathogens like SARS-CoV-2 and Influenza, as well as contaminants in food. This innovative technology aims to enhance public health monitoring and ensure food safety through scalable and cost-effective diagnostics.

Image of DNA and Virus to showcase Scalable Molecular Diagnostics for SARS-CoV-2 with Advanced Microfluidic Chips.

Molecular Diagnostics for SARS-CoV-2

Sensor chip production for a molecular recognition platform in medical diagnostics in general and for SARS-CoV-2 diagnostics (both antibody and viral genetic material testing) in particular.

Photo of AcouSort's acoustofluidic chip for cell trapping under a microscope.

Pioneering Exosome Diagnostics: AcouSome - Acoustic Seperation of Extracellular Vesicles

AcouSome, an initiative by AcouSort, is set to change this by introducing an efficient, automated, and precise solution for exosome isolation.

Photo of VERAXA’s HITMASTER microfluidic droplet sorting device in action.

Revolutionizing Antibody Discovery: VERAXA Biotech's Microfluidic Marvel

VERAXA Biotech GmbH, renowned for their innovative HITMASTER platform, a groundbreaking microfluidic droplet-based screening system that revolutionizes functional antibody discovery.

Photo of Novus Dx’s SepTec technology showcasing its components and the process of sepsis pathogen detection.

Revolutionizing Sepsis Diagnostics - The Novus Dx Technology

Novus Dx’s SepTec technology, developed with the Microfluidics Innovation Hub, revolutionizes sepsis diagnostics by providing rapid and accurate pathogen detection directly from whole blood in just 15 minutes. This near-patient system combines advanced microfluidic and electrochemical technologies to improve patient outcomes through faster, more reliable sepsis diagnosis.

Illustration of ViroGates’ multiplex microfluidic chip and its integration into the GENSPEED® xPOC platform.

Advancing Patient Triage with ViroGates' Multiplex Inflammatory Biomarker Detection

ViroGates, an international in vitro diagnostics company based in Denmark, is renowned for its innovative solutions in emergency medicine. Their suPARnostic® product line, used extensively in emergency departments, enhances clinical decisions regarding the hospitalization or discharge of acute medical patients.

Photo of Hycult Biotech’s multiplex microfluidic chip and its integration into the GENSPEED® xPOC platform for CKD diagnostics.

Advancing Chronic Kidney Disease Diagnostics - Hycult Biotech's Complement Biomarker Assay

Hycult Biotech, together with the Microfluidics Innovation Hub, is developing a rapid, non-invasive multiplex assay for detecting complement activation markers in chronic kidney disease. This advanced microfluidic platform aims to improve early diagnosis and monitoring, offering a reliable alternative to invasive kidney biopsies

Illustration of EXIAS Medical’s microfluidic chip and its integration into the blood analysis device.

Tackling Microfluidic Challenges with EXIAS Medical's Advanced Blood Analysis Device

EXIAS Medical, in partnership with the Microfluidics Innovation Hub, is advancing blood analysis with a microfluidic chip that measures critical blood parameters. This project tackles air bubble formation in microfluidic channels, enhancing sensor accuracy and ensuring reliable point-of-care diagnostics.

Contact us today and together we will evaluate which manufacturing process best suits your microfluidic needs! 

Are you ready to scale-up?

Contact us to discuss your microfluidic project requirements and objectives.


Partner Match

We connect you with the right manufacturing experts from our network.

We oversee the entire project, ensuring smooth coordination and timely delivery

Project Management

bottom of page